| Patent | Date |
|---|
Tobramycin magnesium stearate microparticles for inhalation, compositions thereof, and methods of making and using the same
Grant 10,857,169 - Morton , et al. December 8, 2 | 2020-12-08 |
Method of making particles for use in a pharmaceutical composition
Grant 10,561,613 - Staniforth , et al. Feb | 2020-02-18 |
Process For Providing Particles With Reduced Electrostatic Charges
App 20190216731 - Cocconi; Daniela ; et al. | 2019-07-18 |
Method Of Making Particles For Use In A Pharmaceutical Composition
App 20180055772 - Staniforth; John Nicholas ; et al. | 2018-03-01 |
Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
Grant 9,808,422 - Pasquali , et al. November 7, 2 | 2017-11-07 |
Pharmaceutical formulations for dry powder inhalers
Grant 9,566,239 - Staniforth , et al. February 14, 2 | 2017-02-14 |
Process For Preparing Carrier Particles For Dry Powders For Inhalation
App 20160354314 - MUSA; Rossella ; et al. | 2016-12-08 |
Process for preparing carrier particles for dry powders for inhalation
Grant 9,445,999 - Musa , et al. September 20, 2 | 2016-09-20 |
Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-adrenergic For Administration By Inhalation
App 20160263027 - PASQUALI; Irene ; et al. | 2016-09-15 |
Method Of Making Particles For Use In A Pharmaceutical Composition
App 20160243039 - STANIFORTH; JOHN NICHOLAS ; et al. | 2016-08-25 |
Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
Grant 9,402,825 - Pasquali , et al. August 2, 2 | 2016-08-02 |
Method of making particles for use in a pharmaceutical composition
Grant 9,351,928 - Staniforth , et al. May 31, 2 | 2016-05-31 |
Process For Preparing Carrier Particles For Dry Powders For Inhalation
App 20150202159 - MUSA; Rossella ; et al. | 2015-07-23 |
Process for preparing carrier particles for dry powders for inhalation
Grant 8,974,831 - Musa , et al. March 10, 2 | 2015-03-10 |
Pharmaceutical Formulations For Dry Powder Inhalers
App 20150050350 - Staniforth; John Nicholas ; et al. | 2015-02-19 |
Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-adrenergic For Administration By Inhalation
App 20150017248 - PASQUALI; Irene ; et al. | 2015-01-15 |
Pharmaceutical formulations for dry powder inhalers
Grant 8,871,274 - Staniforth , et al. October 28, 2 | 2014-10-28 |
Micronized particles of low-dosage strength active agents for powder formulations for inhalation
Grant 8,512,753 - Musa , et al. August 20, 2 | 2013-08-20 |
Formulations For Use In Inhaler Devices
App 20120308613 - Staniforth; John Nicholas ; et al. | 2012-12-06 |
Formulations for use in inhaler devices
Grant 8,182,791 - Staniforth , et al. May 22, 2 | 2012-05-22 |
Process For Preparing Carrier Particles For Dry Powders For Inhalation
App 20110262547 - Musa; Rossella ; et al. | 2011-10-27 |
Process For Providing Particles With Reduced Electrostatic Charges
App 20110262543 - Cocconi; Daniela ; et al. | 2011-10-27 |
Antibiotic Microparticles For Inhalation
App 20110139152 - MORTON; David ; et al. | 2011-06-16 |
Particles Comprising A Salt Of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-q- Uinolinone Having Improved Adhesion Properties For Powder Formulations For Inhalation
App 20110097409 - Buttini; Francesca ; et al. | 2011-04-28 |
Method Of Making Particles For Use In A Pharmaceutical Composition
App 20100285142 - Staniforth; John Nicholas ; et al. | 2010-11-11 |
Inhalation Particles Comprising A Salt Of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] Ethyl]-2(1h)-quinolinone And A Corticosteroid
App 20100269825 - COCCONI; Daniela ; et al. | 2010-10-28 |
Micronized Particles Of Low-dosage Strength Active Agents For Powder Formulations For Inhalation
App 20100055192 - Musa; Rossella ; et al. | 2010-03-04 |
Pharmaceutical formulations for dry powder inhalers
App 20090269412 - Staniforth; John Nicholas ; et al. | 2009-10-29 |
Dry Powder Formulation Comprising An Anticholinergic Drug
App 20090192187 - BRAMBILLA; Gaetano ; et al. | 2009-07-30 |
Pharmaceutical formulations for dry powder inhalers
Grant 7,541,022 - Staniforth , et al. June 2, 2 | 2009-06-02 |
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
Grant 7,223,748 - Staniforth , et al. May 29, 2 | 2007-05-29 |
Modified carrier particles for use in dry powder inhalers
Grant 7,132,115 - Musa , et al. November 7, 2 | 2006-11-07 |
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
App 20050201950 - Staniforth, John Nicholas ; et al. | 2005-09-15 |
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
Grant 6,884,794 - Staniforth , et al. April 26, 2 | 2005-04-26 |
Modified carrier particles for use in dry powder inhalers
App 20040096516 - Musa, Rossella ; et al. | 2004-05-20 |
Modified carrier particles for use in dry powder inhalers
App 20040009127 - Musa, Rossella ; et al. | 2004-01-15 |
Modified carrier particles for use in dry powder inhalers
Grant 6,641,844 - Musa , et al. November 4, 2 | 2003-11-04 |
Pharmaceutical formulations for dry powder inhalers
App 20030185764 - Staniforth, John Nicholas ; et al. | 2003-10-02 |
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
App 20030180227 - Staniforth, John Nicholas ; et al. | 2003-09-25 |
Formulations for use in inhaler devices
App 20030175214 - Staniforth, John Nicholas ; et al. | 2003-09-18 |
Powdery pharmaceutical compositions for inhalation
App 20030133880 - Musa, Rossella ; et al. | 2003-07-17 |
Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
Grant 6,528,096 - Musa , et al. March 4, 2 | 2003-03-04 |
| 